261 related articles for article (PubMed ID: 15765775)
1. The effect of antiplatelet autoantibodies on megakaryocytopoiesis.
McMillan R; Nugent D
Int J Hematol; 2005 Feb; 81(2):94-9. PubMed ID: 15765775
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of chronic immune thrombocytopenic purpura.
McMillan R
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S3-S11. PubMed ID: 18096470
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production.
Nugent D; McMillan R; Nichol JL; Slichter SJ
Br J Haematol; 2009 Sep; 146(6):585-96. PubMed ID: 19466980
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis.
Wang L; Li Y; Hou M
Crit Rev Oncol Hematol; 2007 Nov; 64(2):83-9. PubMed ID: 17900920
[TBL] [Abstract][Full Text] [Related]
5. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.
Chang M; Nakagawa PA; Williams SA; Schwartz MR; Imfeld KL; Buzby JS; Nugent DJ
Blood; 2003 Aug; 102(3):887-95. PubMed ID: 12676790
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and pathophysiology of immune thrombocytopenic purpura.
Gernsheimer T
Eur J Haematol Suppl; 2008 Feb; (69):3-8. PubMed ID: 18211567
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
Marini I; Bakchoul T
Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
McMillan R
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
[TBL] [Abstract][Full Text] [Related]
9. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura.
McMillan R
Semin Hematol; 2000 Jan; 37(1 Suppl 1):5-9. PubMed ID: 10676917
[TBL] [Abstract][Full Text] [Related]
10. The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura.
Gernsheimer TB
Hematology Am Soc Hematol Educ Program; 2008; ():219-26. PubMed ID: 19074086
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of chronic immune thrombocytopenic purpura.
Cines DB; McMillan R
Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
[TBL] [Abstract][Full Text] [Related]
12. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.
McMillan R; Wang L; Tomer A; Nichol J; Pistillo J
Blood; 2004 Feb; 103(4):1364-9. PubMed ID: 14576051
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs for immune thrombocytopenia (ITP).
Salama A
Expert Opin Emerg Drugs; 2017 Mar; 22(1):27-38. PubMed ID: 28253829
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology and management of primary immune thrombocytopenia.
Kashiwagi H; Tomiyama Y
Int J Hematol; 2013 Jul; 98(1):24-33. PubMed ID: 23702914
[TBL] [Abstract][Full Text] [Related]
15. The isolation and characterisation of antiplatelet antibodies.
Hamidpour M; Behrendt M; Griffiths B; Partridge L; Lindsey N
Eur J Haematol; 2006 Apr; 76(4):331-8. PubMed ID: 16519705
[TBL] [Abstract][Full Text] [Related]
16. Platelet destruction in immune thrombocytopenia. Understanding the mechanisms.
Bakchoul T; Sachs UJ
Hamostaseologie; 2016 Aug; 36(3):187-94. PubMed ID: 25982994
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura.
McFarland J
Blood Rev; 2002 Mar; 16(1):1-2. PubMed ID: 11913982
[TBL] [Abstract][Full Text] [Related]
18. Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count.
Lev PR; Grodzielski M; Goette NP; Glembotsky AC; Espasandin YR; Pierdominici MS; Contrufo G; Montero VS; Ferrari L; Molinas FC; Heller PG; Marta RF
Br J Haematol; 2014 Jun; 165(6):854-64. PubMed ID: 24673454
[TBL] [Abstract][Full Text] [Related]
19. The ITP syndrome: pathogenic and clinical diversity.
Cines DB; Bussel JB; Liebman HA; Luning Prak ET
Blood; 2009 Jun; 113(26):6511-21. PubMed ID: 19395674
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of hypoxia-inducible factor-1α contributes to impaired megakaryopoiesis in immune thrombocytopenia.
Qi J; You T; Pan T; Wang Q; Zhu L; Han Y
Thromb Haemost; 2017 Oct; 117(10):1875-1886. PubMed ID: 28771276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
